Macular Degeneration Research
Accelerating groundbreaking research into the root causes of leading eye diseases and supporting pioneering prevention strategies and treatments to end macular degeneration in our lifetime.
Our 360° Research Approach
Research We Fund
BrightFocus drives innovative research worldwide on Alzheimer’s, macular degeneration, and glaucoma. Search our grant awards to learn more.
Breakthrough Spotlight
FDA Gives “Breakthrough” Status to Potential New Treatment for Vision Disease
Rooted in key, early funding from BrightFocus, a proposed treatment for Stargardt disease – an inherited blinding retinal degenerative condition beginning in childhood – received “Breakthrough Therapy Designation” from the U.S. Food and Drug Administration, allowing for expedited testing and federal review towards possible patient use.
Insights and Breakthroughs
Well-designed research pays off. With further research, each of these discoveries may contribute to the development of new treatments and preventions.
Donate to Macular Degeneration Research
Your gift can help lead to treatments and a cure to end macular degeneration. Fund the latest, promising research and help provide valuable information to families living with this disease.
Learn about Macular Degeneration
Age-related macular degeneration (AMD) is the leading cause of visual impairment and irreversible vision loss in the United States. In this section, you can find out more about macular degeneration and how you can manage care for yourself or a loved one.